Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pileri

Showing results (631-640 of 992) with videos related to

Pageof 100
Sort By:
Annals of Internal Medicine|September 5, 1998
Prevalence of monoclonal gammopathies in patients with hepatitis C virus infectionP Andreone, A L Zignego, C Cursaro, et al.
The Journal of Pathology|June 1, 1997
Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomasD Spina, L Leoncini, T Megha, et al.
Journal of Vascular and Interventional Radiology : JVIR|October 5, 2023
Percutaneous Cryoablation of Recurrent or Oligometastatic Tumors in Thoracoabdominal Soft Tissues: Safety, Effectiveness, and Technical AspectsGiuseppina Pacella, Carlo Altomare, Matteo Pileri, et al.
Leukemia Research|October 1, 1996
Combined differentiating therapy for myelodysplastic syndromes: a phase II studyD Ferrero, B Bruno, P Pregno, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patientsCinzia Pellegrini, Letizia Gandolfi, Federica Quirini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcomeP L Zinzani, F Venturini, V Stefoni, et al.
The Journal of Biological Chemistry|November 6, 2013
Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencingJihyun Chung, Vrajesh Karkhanis, Sookil Tae, et al.
Bone Marrow Transplantation|September 11, 1998
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myelomaI Majolino, P Corradini, R Scimè, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 17, 2015
Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targetingLi Fan, Susanna Campagnoli, Hong Wu, et al.
The American Journal of Surgical Pathology|July 16, 2014
Cytotoxic T-cell and NK-cell lymphomas: current questions and controversiesSteven H Swerdlow, Elaine S Jaffe, Pierre Brousset, et al.
Pageof 100

Showing results (631-640 of 992) with videos related to

Sort By:
Pageof 100
Annals of Internal Medicine|September 5, 1998
Prevalence of monoclonal gammopathies in patients with hepatitis C virus infectionP Andreone, A L Zignego, C Cursaro, et al.
The Journal of Pathology|June 1, 1997
Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomasD Spina, L Leoncini, T Megha, et al.
Journal of Vascular and Interventional Radiology : JVIR|October 5, 2023
Percutaneous Cryoablation of Recurrent or Oligometastatic Tumors in Thoracoabdominal Soft Tissues: Safety, Effectiveness, and Technical AspectsGiuseppina Pacella, Carlo Altomare, Matteo Pileri, et al.
Leukemia Research|October 1, 1996
Combined differentiating therapy for myelodysplastic syndromes: a phase II studyD Ferrero, B Bruno, P Pregno, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patientsCinzia Pellegrini, Letizia Gandolfi, Federica Quirini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcomeP L Zinzani, F Venturini, V Stefoni, et al.
The Journal of Biological Chemistry|November 6, 2013
Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencingJihyun Chung, Vrajesh Karkhanis, Sookil Tae, et al.
Bone Marrow Transplantation|September 11, 1998
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myelomaI Majolino, P Corradini, R Scimè, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 17, 2015
Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targetingLi Fan, Susanna Campagnoli, Hong Wu, et al.
The American Journal of Surgical Pathology|July 16, 2014
Cytotoxic T-cell and NK-cell lymphomas: current questions and controversiesSteven H Swerdlow, Elaine S Jaffe, Pierre Brousset, et al.
Pageof 100